IGC Appoints Carrolee Barlow, MD, PhD as Advisor to Help Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD) March 12, 2018 Read More »
IGC Partners with Parkinson’s Institute and Clinical Center to Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD) March 1, 2018 Read More »
IGC Announces Third Quarter Financial Results Advances Hyalolex to Commercialization Stage February 20, 2018 Read More »
IGC’s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13 February 12, 2018 Read More »
